Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats-Reference-Cited by-同舟云学术

Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats

Published:2017-11-14 Issue:2 Volume:391 Page:115-121
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Bedada Satish Kumar,Neerati Prasad

Funder

University Grants Commission

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00210-017-1439-3/fulltext.html

Reference26 articles.

1. Basheer L, Kerem Z (2015) Interactions between CYP3A4 and dietary polyphenols. Oxidative Med Cell Longev 2015:854015

2. Bear WL, Teel RW (2010) Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res 20:3323–3329

3. Bedada SK, Boga PK (2017) Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects. Xenobiotica 47(10):879–884. https://doi.org/10.1080/00498254.2016.1244368

4. Chi YC, Lin SP, Hou YC (2012) A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats. Toxicol Appl Pharmacol 263(3):315–322. https://doi.org/10.1016/j.taap.2012.07.003

5. Cho YA, Choi JS, Burm JP (2011) Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein. Pharmacol Rep 63(4):1066–1073. https://doi.org/10.1016/S1734-1140(11)70624-7

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Diosmin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Rats;Current Pharmaceutical Analysis;2024-05

2. Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports;International Journal of Molecular Sciences;2023-11-05

3. Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro;Human & Experimental Toxicology;2022-01

4. Overview of Quality Control and Pharmaco-Kinetic of Citrus Bioflavonoids Tablets;Pharmacy Information;2022

5. RETRACTED: Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro;Human & Experimental Toxicology;2021-11-16